QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
NASDAQ:BCPC

Balchem (BCPC) Stock Forecast, Price & News

$125.93
+2.55 (+2.07%)
(As of 09/28/2023 ET)
Compare
Today's Range
$123.61
$126.91
50-Day Range
$123.38
$142.72
52-Week Range
$116.68
$143.88
Volume
162,474 shs
Average Volume
93,658 shs
Market Capitalization
$4.06 billion
P/E Ratio
41.02
Dividend Yield
0.56%
Price Target
$165.00

Balchem MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
31.0% Upside
$165.00 Price Target
Short Interest
Healthy
0.70% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.54
Upright™ Environmental Score
News Sentiment
1.20mentions of Balchem in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$499,966 Sold Last Quarter
Proj. Earnings Growth
12.68%
From $3.47 to $3.91 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.00 out of 5 stars

Basic Materials Sector

15th out of 167 stocks

Chemicals & Allied Products Industry

4th out of 15 stocks


BCPC stock logo

About Balchem (NASDAQ:BCPC) Stock

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; single use canisters for sterilizing re-usable devices; and ammonia. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in Montvale, New Jersey.

BCPC Price History

BCPC Stock News Headlines

Balchem (NASDAQ: BCPC)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Q2 2023 Balchem Corp Earnings Call
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Balchem: A Mixed Quarter
Q1 2023 Balchem Corp Earnings Call
Balchem Full Year 2022 Earnings: EPS Misses Expectations
Q4 2022 Balchem Corp Earnings Call
See More Headlines
Receive BCPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter.

BCPC Company Calendar

Last Earnings
7/28/2023
Today
9/28/2023
Next Earnings (Estimated)
11/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
Specialty Chemicals
Current Symbol
NASDAQ:BCPC
CUSIP
05766520
CIK
9326
Employees
1,340
Year Founded
1967

Price Target and Rating

Average Stock Price Forecast
$165.00
High Stock Price Forecast
$165.00
Low Stock Price Forecast
$165.00
Forecasted Upside/Downside
+30.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$105.37 million
Pretax Margin
13.22%

Debt

Sales & Book Value

Annual Sales
$942.36 million
Cash Flow
$5.00 per share
Book Value
$29.20 per share

Miscellaneous

Free Float
31,669,000
Market Cap
$4.07 billion
Optionable
Optionable
Beta
0.69

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Theodore L. Harris (Age 58)
    Chairman, CEO & Pres
    Comp: $2.33M
  • Mr. Carl Martin Bengtsson (Age 45)
    Exec. VP, CFO & Treasurer
    Comp: $864.13k
  • Ms. Hatsuki Miyata (Age 47)
    Exec. VP, Gen. Counsel & Sec.
    Comp: $618.21k
  • Mr. Jonathan H. Griffin (Age 47)
    Sr. VP and GM of Animal Nutrition & Health
    Comp: $624.01k
  • Mr. Martin Luther Reid (Age 55)
    Sr. VP & Chief Supply Chain Officer
    Comp: $672.26k
  • Mr. William A. Backus CPA (Age 57)
    CPA, VP & CAO
  • Mr. Michael R. Sestrick Ph.D. (Age 59)
    Sr. VP & CTO
  • Mr. Brent Tignor (Age 45)
    Sr. VP & Chief HR Officer
  • Mr. Frederic Boned (Age 45)
    Sr. VP and GM of Human Nutrition & Health
  • Mr. Job L. van Gunsteren (Age 47)
    Sr. VP & GM of Specialty Products













BCPC Stock - Frequently Asked Questions

Should I buy or sell Balchem stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BCPC shares.
View BCPC analyst ratings
or view top-rated stocks.

What is Balchem's stock price forecast for 2023?

1 equities research analysts have issued 12-month price targets for Balchem's stock. Their BCPC share price forecasts range from $165.00 to $165.00. On average, they predict the company's stock price to reach $165.00 in the next year. This suggests a possible upside of 30.7% from the stock's current price.
View analysts price targets for BCPC
or view top-rated stocks among Wall Street analysts.

How have BCPC shares performed in 2023?

Balchem's stock was trading at $122.11 at the start of the year. Since then, BCPC stock has increased by 3.4% and is now trading at $126.21.
View the best growth stocks for 2023 here
.

Are investors shorting Balchem?

Balchem saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 222,600 shares, an increase of 5.8% from the August 31st total of 210,300 shares. Based on an average daily volume of 85,300 shares, the short-interest ratio is currently 2.6 days. Approximately 0.7% of the company's stock are short sold.
View Balchem's Short Interest
.

When is Balchem's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, November 3rd 2023.
View our BCPC earnings forecast
.

How were Balchem's earnings last quarter?

Balchem Co. (NASDAQ:BCPC) posted its quarterly earnings data on Friday, July, 28th. The basic materials company reported $0.93 EPS for the quarter, topping analysts' consensus estimates of $0.80 by $0.13. The basic materials company earned $231.25 million during the quarter, compared to the consensus estimate of $241 million. Balchem had a net margin of 10.58% and a trailing twelve-month return on equity of 10.43%.

How often does Balchem pay dividends? What is the dividend yield for Balchem?

Balchem announced an annual dividend on Tuesday, December 6th. Investors of record on Tuesday, December 27th will be given a dividend of $0.71 per share on Friday, January 20th. This represents a dividend yield of 0.53%. The ex-dividend date is Friday, December 23rd. This is a positive change from the stock's previous annual dividend of $0.64.
Read our dividend analysis for BCPC
.

Is Balchem a good dividend stock?

Balchem (NASDAQ:BCPC) pays an annual dividend of $0.71 per share and currently has a dividend yield of 0.57%. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 23.13%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BCPC will have a dividend payout ratio of 18.16% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BCPC.

What is Dino A. Rossi's approval rating as Balchem's CEO?

25 employees have rated Balchem Chief Executive Officer Dino A. Rossi on Glassdoor.com. Dino A. Rossi has an approval rating of 85% among the company's employees. 62.0% of employees surveyed would recommend working at Balchem to a friend.

What other stocks do shareholders of Balchem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL), CVS Health (CVS), AbbVie (ABBV), Johnson & Johnson (JNJ), Lowe's Companies (LOW), Altria Group (MO), NVIDIA (NVDA), AT&T (T), Analog Devices (ADI) and Bristol-Myers Squibb (BMY).

What is Balchem's stock symbol?

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Who are Balchem's major shareholders?

Balchem's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.17%), Wasatch Advisors LP (6.15%), State Street Corp (3.44%), Conestoga Capital Advisors LLC (3.27%), Bank Julius Baer & Co. Ltd Zurich (2.38%) and Geneva Capital Management LLC (2.36%). Insiders that own company stock include David B Fischer, Gunsteren Job Leonard Van, Michael Robert Sestrick, Scott C Mason and William A Backus.
View institutional ownership trends
.

How do I buy shares of Balchem?

Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Balchem's stock price today?

One share of BCPC stock can currently be purchased for approximately $126.21.

How much money does Balchem make?

Balchem (NASDAQ:BCPC) has a market capitalization of $4.07 billion and generates $942.36 million in revenue each year. The basic materials company earns $105.37 million in net income (profit) each year or $3.07 on an earnings per share basis.

How many employees does Balchem have?

The company employs 1,340 workers across the globe.

Does Balchem have any subsidiaries?
The following companies are subsidiares of Balchem: Aberco Inc., Aberco Inc., Albion Laboratories Inc., Albion Laboratories Inc., BCP Ingredients Inc., Balchem BV, Balchem Italia Srl, Balchem Ltd., Balchem NV, Balchem Pte Ltd., Balchem Pty Ltd., Balchem Sdn Bhd, Bioscreen technologies, Chemogas Holding NV, Chol-Mix Kft, Innovative Food Processors, SensoryEffects, SensoryEffects Cereal Systems Inc., SensoryEffects Inc., Stereo Gas Philippines Inc., and Zumbro River Brand Inc..
Read More
How can I contact Balchem?

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The official website for the company is www.balchem.com. The basic materials company can be reached via phone at (845) 326-5600, via email at mabrush@balchem.com, or via fax at 845-326-5717.

This page (NASDAQ:BCPC) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -